Electrophysiology

The cardiac subspecialty of electrophysiology (EP) diagnoses and treats arrhythmias. This includes use of pacemakers to treat bradycardia, implantable cardioverter defibrillators (ICD) for tachycardia, heart failure and patients at risk of sudden cardiac arrest, and cardiac ablation treatments to treat heart rhythm disorders.

FDA announces recall of cryoablation catheters after multiple injuries, including 4 deaths
Boston Scientific is recalling the catheters associated with its POLARx Cryoablation System due to a heightened risk of esophageal injury. The FDA has ruled that this a Class I recall.
Cardiologists perform world’s first leadless LBBAP procedures with Abbott pacemaker
The first-in-human procedures were performed in Prague with the investigational Aveir CSP leadless pacemaker system.
President of medical device company resigns over conduct allegations after 7 months in role
Joseph C. Wright, a longtime Merit Medical employee, resigned after unspecified allegations regarding his conduct were brought to light. He was named the company's new president back in May.
FDA and Boston Scientific issue urgent alert about pacemaker failures following 2 deaths
The U.S. Food and Drug Administration issued the recall notice for more than 200,000 pacemakers because a battery issue could lock the device in safe mode.
Treating AFib patients with TAVR still linked to elevated risks
While the technology and techniques associated with TAVR have advanced over the years, treating patients who present with baseline atrial fibrillation is still associated with certain risks.

device implantation during left atrial appendage occlusion (LAAO) procedures

Mitigating risk: How the depth of device implantation impacts LAAO outcomes

Researchers examined data from more than 1,300 procedures, presenting their findings in JACC: Cardiovascular Interventions.

August 18, 2023

A complete list of the European Society of Cardiology (ESC) 2023 Congress late-breaking Hot Line sessions. #ESCCongress

ESC Congress 2023 to feature 30 late-breaking clinical trials

The European Society of Cardiology's annual meeting is scheduled for Aug. 25-28, 2023, in Amsterdam.

August 18, 2023

FDA clears 2 new AI models that help with the diagnosis and treatment of arrhythmias

The two algorithms are now commercially available on a price-per-use basis.

August 16, 2023

FDA highlights importance of including heart rhythm risks on drug labels

The agency has shared a new draft guidance focused on the inclusion of information related to QTc interval prolongation.

August 10, 2023

Boston Scientific’s POLARx Cryoablation System for atrial fibrillation gained FDA approval in August 2023.

FDA approves Boston Scientific’s new cryoablation system for AFib

The system includes an expandable cryoablation balloon catheter compatible with multiple balloon sizes.

August 9, 2023

NFL player feeling thankful after AFib diagnosis: ‘I think it’s just the good Lord looking after me’

Tyler Shatley, a veteran offensive lineman with the Jacksonville Jaguars, said he experienced symptoms for years before finally seeking a diagnosis.

August 7, 2023

The ThermoCool SmartTouch SF catheter from Biosense Webster

FDA approves several Biosense Webster devices for fluoroscopy-free ablation procedures

Using these devices as part of a zero-fluoroscopy workflow, which replaces X-rays with an alternative modality such as ultrasound, limits radiation exposure and the use of burdensome protective equipment.

August 4, 2023

The 25 best U.S. cardiology hospitals ranked

U.S. News & World Report's annual rankings of heart hospitals named Cleveland Clinic No. 1, once again, but there were many changes among the other top 25 hospitals.

August 2, 2023

Electrophysiology

FDA announces recall of cryoablation catheters after multiple injuries, including 4 deaths

Cardiologists perform world’s first leadless LBBAP procedures with Abbott pacemaker

President of medical device company resigns over conduct allegations after 7 months in role

FDA and Boston Scientific issue urgent alert about pacemaker failures following 2 deaths

Treating AFib patients with TAVR still linked to elevated risks